Markets
TNYA

Tenaya Therapeutics Appoints Eric Hyllengren As CFO

June 29, 2026 — 08:56 am EDT

Written by RTTNews.com for RTTNews->

(RTTNews) - Tenaya Therapeutics, Inc. (TNYA), a clinical-stage biotechnology company, said on Monday that it has appointed Eric Hyllengren as Chief Financial Officer with effect from July 13.

Hyllengren most recently served as CFO of Zura Bio. Prior to Zura Bio, he served as CFO and Chief Operating Officer of Atara Biotherapeutics.

Earlier, he held roles of increasing responsibility across finance, investor relations, and business development over the course of 15 years at Amgen.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Tags

Markets
RTTNews
Founded in the late 1990s by Andrew Mariathasan in New York, with the goal of covering Wall Street for a new generation of investors, RTTNews has expanded steadily over the years to become a trusted provider of content for a wide array of subjects across several platforms. RTT's Financial Newswire is relied upon by some of the world's largest financial institutions, including banks, brokerages, trading platforms and financial exchanges.
More articles by this source->

Stocks mentioned

TNYA

More Related Articles

Info icon

This data feed is not available at this time.

Data is currently not available

  • •

Sign up for the TradeTalks newsletter to receive your weekly dose of trading news, trends and education. Delivered Wednesdays.